Page 76 - Read Online

Page 10 of 11 Zlatkina et al. Vessel Plus 2019;3:7 I http://dx.doi.org/10.20517/2574-1209.2019.03

12. Ametov AS, Demidova TY, Tselikovskaya AL. Obesity and cardiovascular diseases. Therapeutic Archive 2001;73:66-9. (in Russian)
13. Kaneto H, Miyatsuka T, Shiraiwa T, Yamamoto K, Kato K, et al. Crucial role of PDX-1 in pancreas development, beta-cell
differentiation, and induction of surrogate beta-cells. Cur Med Chem 2007;14:1745-52.
14. Nishimura W, Bonner-Weir S, Sharma A. Expression of MafA in pancreatic progenitors is detrimental for pancreatic development. Dev
Biol 2009;333:108-20.
15. Artner I, Hang Y, Guo M, Gu G, Stein R. MafA is a dedicated activator of the insulin gene in vivo. J. Endocrinol 2008;198:271-9.
16. Unger RH. The physiology of cellular liporegulation. Annu Rev Physiol 2003;65:333-47.
17. Prentki M, Joly E, El-Assaad W, Roduit R. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in β-cell adaptation
and failure in the etiology of diabetes. Diabetes 2002;51:S405-13.
18. Ashcroft FM, Rohm M, Clark A, Brereton MF. Is type 2 diabetes a glycogen storage disease of pancreatic β cells? Cell Metab
2017;26:17-23.
19. Pelikánova T. Treatment of diabetes in metabolic syndrome. Vnitr Lek 2009;55:637-45.
20. Schatz H. 2008--The year of the big studies about the therapy of type-2-diabetes. ACCORD, ADVANCE, VADT, and the UKPDS 10-
year follow-up data. MMW Fortschr Med 2009;151:42-3.
21. Burkhardt BR, Cook JR, Young RA, Wolf BA. PDX-1 interaction and regulation of the Pancreatic Derived Factor (PANDER, FAM3B)
promoter. Biochim Biophys Acta 2008;1779:645-51.
22. Stanojevic V, Habener JF, Thomas MK. Pancreas duodenum homeobox-1 transcriptional activation requires interactions with p300.
Endocrinology 2004;145:2918-28.
23. Gao Y, Miyazaki J, Hart GW. The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this
modification is correlated with its DNA binding activity and insulin secretion in min6 ß-cells. Arch Biochem Biophys 2003;415:155-63.
24. Kishi A, Nakamura T, Nishio Y, Maegawa H, Kashiwagi A. Sumoylation of Pdx1 is associated with its nuclear localization and insulin
gene activation. Am J Physiol Endocrinol Metab 2003;284:E830-40.
25. da Silva Xavier G, Varadi A, Ainscow EK, Rutter GA. Regulation of gene expression by glucose in pancreatic ß-cells (MIN6) via
insulin secretion and activation of phosphatidylinositol 3’-kinase. J Biol Chem 2000;275:36269-77.
26. Khoo S, Griffen SC, Xia Y, Baer RJ, German MS, et al. Regulation of insulin gene transcription by ERK1 and ERK2 in pancreatic ß
cells. J Bio Chem 2003;278:32969-77.
27. Zangen DH, Bonner-Weir S, Lee CH, Latimer JB, Miller CP, et al. Reduced insulin, GLUT2, and IDX-1 in ß-cells after partial
pancreatectomy. Diabetes 1997;46:258-64.
28. Leibowitz G, Ferber S, Apelqvist A, Edlund H, Gross DJ, et al. IPF1/PDX1 deficiency and ß-cell dysfunction in Psammomysobesus, an
animal with type 2 diabetes. Diabetes 2001;50:1799-806.
29. Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty
rats by antioxidants. Proc Natl Acad Sci U S A 1999;96:10857-62.
30. Tajiri Y, Moller C, Grill V. Long term effects of aminoguanidine on insulin release and biosynthesis: evidence that the formation of
advanced glycosylation end products inhibits β-cell function. Endocrinology 1997;138:273-80.
31. Green K, Brand MD, Murphy MP. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes
2004;53:S110-8.
32. Gopaul NK, Anggård EE, Mallet AI, Betteridge DJ, Wolff SP, et al. Plasma 8-epi-PGF2 levels are elevated in individuals with non-
insulin dependent diabetes mellitus. FEBS Lett 1995;368:225-9.
33. Yoshida K, Hirokawa J, Tagami S, Kawakami Y, Urata Y, et al. Weakened cellular scavenging activity against oxidative stress in
diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 1995;38:201-10.
34. Chaurasia B, Summers SA. Ceramides - lipotoxic inducers of metabolic disorders: (Trends in Endocrinology and Metabolism 26, 538-
550; 2015). Trends Endocrinol Metab 2018;29:66-7.
35. Hagman DK, Hays LB, Parazzoli SD, Poitout V. Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and
reducing MafA expression in isolated rat islets of Langerhans. J Biol Chem 2005;280:32413-8.
36. Briaud I, Harmon JS, Kelpe CL, Segu VB, Poitout V. Lipotoxicity of the pancreatic ß-cell is associated with glucose-dependent
esterification of fatty acids into neutral lipids. Diabetes 2001;50:315-21.
37. Gwiazda KS, Yang T, Lin Y, Johnson JD. Effects of palmitate on ER and cytosolic Ca2+ homeostasis in beta-cells. Am J Physiol
Endocrinol Metab 2009;296:E690-701.
38. Widenmaier SB, Ao Z, Kim SJ, Warnock G, McIntosh CH. Suppression of p38 MAPK and JNK via Akt-mediated inhibition
of apoptosis signal-regulating kinase 1constitutes a core component of the beta-cell pro-survival effects of glucose-dependent
insulinotropic polypeptide. J Biol Chem 2009;284:30372-82.
39. Kaneto H, Miyatsuka T, Shiraiwa T, Yamamoto K, Kato K, et al. Crucial role of PDX-1 in pancreas development, beta-cell
differentiation, and induction of surrogate beta-cells. Curr Med Chem 2007;14:1745-52.
40. Vallerie SN, Furuhashi M, Fucho R, Hotamisligil GS. A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the
regulation of systemic insulin sensitivity. PLoS One 2008;3:e3151.
41. Kawamori D, Kaneto H, Nakatani Y, Matsuoka TA, Matsuhisa M, et al. The forkhead transcription factor Foxo1 bridges the JNK
pathway and the transcription factor PDX-1 through its intracellular translocation. J Biol Chem 2006;281:1091-8.
42. Weber C, Krueger A, Münk A, Bode C, Van Veldhoven PP, et al. Discontinued postnatal thymocyte development in sphingosine
1-phosphate-lyase-deficient mice. J Immunol 2009;183:4292-301.